Bihui Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bihui Chen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Dandan Lv
School of Nursing, Peking University, Beijing 100191, China
2 shared publications - Jiahe Li
School of Nursing, Peking University, Beijing 100191, China
2 shared publications - Ning Liu
School of Nursing, Peking University, Beijing 100191, China
2 shared publications - Shuangjin Li
School of Nursing, Peking University, Beijing 100191, China
2 shared publications - Xiu Zhu
School of Nursing, Peking University, Beijing, China
2 shared publications - Wenjia Dong
Rocket Force Characteristic Medical Center, Beijing 100088, China, China
1 shared publication
Latest Publications
- Open Access
Best Evidence Summary of Folic Acid Supplementation for Prevention of Neural Tube Defects in Women of Childbearing Age
Objectives: To summarize the best evidence regarding folic acid supplementation for preventing neural tube defects (NTDs) in women of childbearing age and to develop a structured evidence summary for guiding clinical practice. Methods: We systematically searched multiple databases and professional websites from 1 January 2013 to 18 September 2025. Sources included 7 databases and 20 professional websites. The search targeted clinical guidelines, expert consensuses, best practices, and recommended practices on folic acid supplementation for NTD prevention in women of childbearing age. The retrieved literature underwent quality assessment, evidence extraction, and summarization. Results: The review included 17 publications: 10 guidelines, 4 expert consensuses, 2 recommended practices, and 1 best practice. From these, 14 distinct evidence statements were synthesized and organized into five thematic dimensions: risks of neural tube defects and the role of folic acid, time window of neural tube closure, timing and dosage of folic acid supplementation, relationship between dietary folic acid and folic acid tablets, and folic acid-related testing. The key recommendations include initiating supplementation at least 3 months preconception, with daily doses of 0.4 mg for low-risk, 1.0 mg for moderate-risk, and 4.0–5.0 mg for high-risk women, continuing through the first trimester, emphasizing that dietary intake alone is insufficient, and advising against routine folate testing. Conclusions: This study synthesized the best available evidence regarding folic acid supplementation for preventing NTDs in women of childbearing age, providing an evidence-based foundation to inform clinical practice, particularly for healthcare systems and populations in regions without mandatory folic acid food fortification.
Open AccessBest Evidence Summary of Folic Acid Supplementation for Prevention of Neural Tube Defects in Women of Childbearing Age
Objectives: To summarize the best evidence regarding folic acid supplementation for preventing neural tube defects (NTDs) in women of childbearing age and to develop a structured evidence summary for guiding clinical practice. Methods: We systematically searched multiple databases and professional websites from 1 January 2013 to 18 September 2025. Sources included 7 databases and 20 professional websites. The search targeted clinical guidelines, expert consensuses, best practices, and recommended practices on folic acid supplementation for NTD prevention in women of childbearing age. The retrieved literature underwent quality assessment, evidence extraction, and summarization. Results: The review included 17 publications: 10 guidelines, 4 expert consensuses, 2 recommended practices, and 1 best practice. From these, 14 distinct evidence statements were synthesized and organized into five thematic dimensions: risks of neural tube defects and the role of folic acid, time window of neural tube closure, timing and dosage of folic acid supplementation, relationship between dietary folic acid and folic acid tablets, and folic acid-related testing. The key recommendations include initiating supplementation at least 3 months preconception, with daily doses of 0.4 mg for low-risk, 1.0 mg for moderate-risk, and 4.0–5.0 mg for high-risk women, continuing through the first trimester, emphasizing that dietary intake alone is insufficient, and advising against routine folate testing. Conclusions: This study synthesized the best available evidence regarding folic acid supplementation for preventing NTDs in women of childbearing age, providing an evidence-based foundation to inform clinical practice, particularly for healthcare systems and populations in regions without mandatory folic acid food fortification.
- Open Access
- 24 December 2025
- Published by MDPI AG in Preprints.org
Best Evidence Summary of Folic Acid Supplementation for Prevention of Neural Tube Defects in Women of Childbearing Age
Objectives: To summarize the best evidence regarding folic acid supplementation for preventing neural tube defects (NTDs) in women of childbearing age and to develop a structured evidence summary for guiding clinical practice. Methods: We systematically searched multiple databases and professional websites from January 1, 2013, to September 18, 2025. Sources included 7 databases (PubMed, Embase, CINAHL, Web of Science, CNKI, Wanfang, VIP) and 20 professional websites (e.g., Medlive, GIN, NICE, ACOG, UpToDate, Chinese Medical Knowledge Database, etc.). The search targeted clinical guidelines, expert consensuses, and recommended practices on folic acid supplementation for NTD prevention in women of childbearing age. The retrieved literature underwent quality assessment, evidence extraction, and summarization. Results: The review included 17 publications: 8 guidelines, 4 expert consensuses, and 5 recommended practices. From these, we synthesized 14 distinct evidence statements, organized into five thematic dimensions: risks of neural tube defects and the role of folic acid, time window of neural tube closure, timing and dosage of folic acid supplementation, relationship between dietary folic acid and folic acid tablets, and folic acid-related testing. Conclusions: his study synthesized the best available evidence regarding folic acid supplementation for preventing NTDs in women of childbearing age, providing an evidence-based foundation to inform clinical practice. Future implementation efforts should focus on integrating recommendations into electronic health systems, developing precision public health interventions, and employing visual aids for health education.
- 24 December 2025
- Published by MDPI AG in Preprints.org
Open AccessBest Evidence Summary of Folic Acid Supplementation for Prevention of Neural Tube Defects in Women of Childbearing Age
Objectives: To summarize the best evidence regarding folic acid supplementation for preventing neural tube defects (NTDs) in women of childbearing age and to develop a structured evidence summary for guiding clinical practice. Methods: We systematically searched multiple databases and professional websites from January 1, 2013, to September 18, 2025. Sources included 7 databases (PubMed, Embase, CINAHL, Web of Science, CNKI, Wanfang, VIP) and 20 professional websites (e.g., Medlive, GIN, NICE, ACOG, UpToDate, Chinese Medical Knowledge Database, etc.). The search targeted clinical guidelines, expert consensuses, and recommended practices on folic acid supplementation for NTD prevention in women of childbearing age. The retrieved literature underwent quality assessment, evidence extraction, and summarization. Results: The review included 17 publications: 8 guidelines, 4 expert consensuses, and 5 recommended practices. From these, we synthesized 14 distinct evidence statements, organized into five thematic dimensions: risks of neural tube defects and the role of folic acid, time window of neural tube closure, timing and dosage of folic acid supplementation, relationship between dietary folic acid and folic acid tablets, and folic acid-related testing. Conclusions: his study synthesized the best available evidence regarding folic acid supplementation for preventing NTDs in women of childbearing age, providing an evidence-based foundation to inform clinical practice. Future implementation efforts should focus on integrating recommendations into electronic health systems, developing precision public health interventions, and employing visual aids for health education.